gmpeye´Â ´ëÇѹα¹ Á¦¾à¾÷°èÀÇ GMP Think-Tank¸¦ Ãß±¸ÇÕ´Ï´Ù.

       gmpeye

¡« home ¡« gmp guides & guidelines ¡« specialty services ¡«

GMP ±³À° / ÄÁ¼³ÆÃ / GMP ¹®¼­ ¹ø¿ª

Korean GMP

US FDA CGMP

US FDA guidelines

EU GMP guides

EMA Q-guidelines

ICH API GMP

ICH Q/M(CTD)

WHO GMP

CGMP Q&A

QbD Issues

e-newsletter

 

 

GMP Case Study: Lessons from FDA 483s & Warning Letters

 


gmpeye's missions

 

gmpeye´Â ´ëÇѹα¹ Á¦¾à¾÷°èÀÇ GMP Think-Tank¸¦ Ãß±¸ÇÕ´Ï´Ù.

gmpeye´Â GMP Áö½Ä ¼¾Å͸¦ Ãß±¸ÇÕ´Ï´Ù.

gmpeye´Â Áö½Ä°ú Á¤º¸ÀÇ °øÀ¯ ¹× È®»êÀ» ÅëÇØ GMP ±â¼úÀÇ º¸ÆíÀû ¹ßÀüÀ» Ãß±¸ÇÕ´Ï´Ù.


gmpeye´Â . . .

 

gmpeye´Â ¹Ì±¹ FDA(Food and Drug Administration)¿Í À¯·´ EMEA(European Medicines Agency), ICH(International Conference on Harmonisation), WHO(World Health Organization)ÀÇ ÀڷḦ Áß½ÉÀ¸·Î °ø½Ä GMP ±âÁذú °¢Á¾ °¡À̵å¶óÀÎÀ» ¹ø¿ªÇØ ¿µÇÑ ´ë¿ªÀ¸·Î Á¦°øÇÕ´Ï´Ù.

 

GMP°¡ ¼±Áø ¿Ü±¹¿¡¼­ ½ÃÀÛµÇ¾î ¼öÀÔµÈ °ÍÀ̸ç ÀǾàǰÀÇ ÇØ¿Ü ¼öÃâÀ» À§Çؼ­´Â ¿Ü±¹ ±¹°¡ ±â°üÀ̳ª ±¹Á¦ ±â±¸¿¡¼­ ¹ßÇàÇÑ ±âÁØÀ» µû¸£Áö ¾ÊÀ» ¼ö ¾ø±â ¶§¹®ÀÔ´Ï´Ù.

 

¹Ì±¹°ú À¯·´ÀÇ GMP ±âÁØÀº »ç¶÷ ÀǾàǰ°ú µ¿¹° ÀǾàǰ ¸ðµÎ¿¡ µ¿ÀÏÇÏ°Ô Àû¿ëµË´Ï´Ù.


gmpeye´Â . . .

 

¶ÇÇÑ gmpeye´Â GMP ¿øÄ¢°ú öÇÐÀ» Á߽ɿ¡ µÎ°í, ¿Ü±¹ ±¹°¡ ±â°ü ¹× ±¹Á¦ ±â±¸ÀÇ °¡À̵å¶óÀΰú Á¦¾à¾÷°èÀÇ "current practices"¸¦ °í·ÁÇØ, °íǰÁúÀÇ GMP ÄÁ¼³ÆÃ ¼­ºñ½º¿Í on-site workshop ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´ÙgmpeyeÀÇ ±³À° ÇÁ·Î±×·¥Àº ¹ýÀû ±âÁØÀÇ Áؼö¿¡ ¸Ó¹«¸£Áö ¾Ê°í, »ý»êÀûÀΠGMP ½Ã½ºÅÛÀÇ ±¸ÃàÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.


contact information

 

±è¼¼Áß

ÀüÈ­: 010-9950-4087

e-mail: gmpeye@hanmail.net, gmpeye@gmpeye.co.kr


 

 

 

 

 

gmpeyelogo.gif

Copyright ¨Ï gmpeye. Since 2005. All rights reserved.